NPHLA Intelligence
Sunday, November 15, 2026Updated Nov 14, 2026, 2:35 PM EST
Professional intelligence from official records, research and the industry’s reporting. Every briefing shows its sources. Information, never medical or legal advice.
Top story
Every new official record on the Metabolic & Weight-Loss Intelligence desk since this morning, each linked to its primary source.
NPHLA tracked 15 new official records on this desk today: 2 new studies, 13 trial updates.
Why it matters: GLP-1 and obesity-medicine developments can change access, supply, clinical evidence and patient conversations for clinics, pharmacies and prescribers.
Every new official record on the Metabolic & Weight-Loss Intelligence desk since this morning, each linked to its primary source.
Automated from official records2 sources1 min read
Every new official record on the Metabolic & Weight-Loss Intelligence desk since this morning, each linked to its primary source.
Automated from official records6 sources1 min read
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
Automated from official records1 source1 min read
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records1 source1 min read
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
Automated from official records3 sources1 min read
Every new official record on the AI, Technology & Practice Growth desk since this morning, each linked to its primary source.
Automated from official records3 sources1 min read
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records4 sources1 min read
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
Automated from official records3 sources1 min read
Every new official record on the AI, Technology & Practice Growth desk since this morning, each linked to its primary source.
Automated from official records4 sources1 min read
Every new official record on the Aesthetics, Regenerative & Longevity Medicine desk since this morning, each linked to its primary source.
Automated from official records2 sources1 min read
Boehringer Ingelheim. Conditions: Healthy; Obesity; Overweight. Investigational — not approved for the use studied.
Korea United Pharm. Inc.. Conditions: Bioequivalence; Pharmacokinetics. Investigational — not approved for the use studied.
Hangzhou Sciwind Biosciences Co., Ltd.. Conditions: Food Effect in Healthy Volunteers; Weight Management. Investigational — not approved for the use studied.
Lembas. Conditions: Appetite and Hunger, Suppression; Satiety and Appetite; Weight Change; Gastrointestinal Symptoms; Body Composition. Investigational — not approved for the use studied.
Research summaries link to PubMed records. A single study rarely settles a clinical question.
The FDA, the Federal Register, ClinicalTrials.gov, PubMed and other primary records are monitored around the clock — by servers, not people’s laptops.
Each briefing ends with a numbered Source File. Facts link to the record they come from, and source types are labelled.
AI helps draft briefings from the sources. Sensitive topics — dosing, safety, legal interpretation, named businesses — always go to an NPHLA editor.
If nothing meaningful happened, we publish nothing new. Corrections are shown openly, and published stories are never silently rewritten.
NPHLA Daily · The NPHLA Week
A short weekday briefing at 6 a.m. Eastern and a Monday wrap-up of the week. Members can tailor desks and alerts in their account.
Already a member? Manage your Intelligence emails.
